Cambridge, United Kingdom

Carole Anastasi

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Nr Saffron Walden, GB (2015)
  • Nr. Saffron Walden, GB (2016 - 2017)
  • Cambridge, GB (2022 - 2024)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Carole Anastasi: Innovator in Fluorescent Label Technologies

Introduction

Carole Anastasi is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of fluorescent labels, holding a total of 12 patents. Her work focuses on developing innovative compounds that enhance nucleic acid sequencing applications.

Latest Patents

Among her latest patents are "Substituted coumarin dyes and uses as fluorescent labels" and "Cyclooctatetraene containing dyes and compositions." The first patent relates to substituted coumarin derivatives that serve as fluorescent labels for nucleotides in nucleic acid sequencing applications. The second patent discusses cyclooctatetraene containing dyes and their applications as fluorescent labels, which can be utilized in various biological applications, including nucleic acid sequencing.

Career Highlights

Carole Anastasi is currently associated with Illumina Cambridge Limited, where she continues to push the boundaries of innovation in her field. Her expertise in fluorescent label technologies has positioned her as a key player in the industry.

Collaborations

Throughout her career, Carole has collaborated with notable colleagues, including Nikolai Nikolaevich Romanov and Patrick McCauley. These collaborations have further enriched her research and development efforts.

Conclusion

Carole Anastasi's contributions to the field of fluorescent labels are noteworthy, and her innovative patents continue to impact nucleic acid sequencing applications. Her work exemplifies the importance of innovation in advancing scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…